Skip to content

Blog

Category: Biomarkers

<a href="https://www.bioagilytix.com/blog/category/biomarkers/">Biomarkers</a>

Is ISR Needed For Biomarker Assays?

  • September 12, 2022

Incurred sample reanalysis (ISR) is a well-established measure for the reproducibility of pharmacokinetic (PK) assays and commonly conducted in regulated studies. ISR was established in…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/biomarkers/">Biomarkers</a>

Difference Between Biobetters and Biosimilars

  • November 13, 2020

According to research compiled by Reports and Data, in 2018 the global biologics market was valued at over $250 million, but is projected to reach…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/biomarkers/">Biomarkers</a>

C-Path “Points to Consider Document” Clarifies Bioanalytical Assay Validation in Support of Clinical Biomarker Qualification

  • August 13, 2019

A contributing author to the Critical Path Institute (C-Path)’s “Points to Consider Document,” Dr. Afshin Safavi summarizes considerations outlined in the paper designed to establish…

Find Out More
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>

510K Approved Assays vs. RUO Assays: Which Best Support Clinical Trial Biomarker Studies?

  • July 11, 2019

The answer to the question is “it depends”. Commonly a combination of 510K approved kits (in Europe known as assays that need to follow IVD-directive…

Find Out More